A novel recombinant human microplasminogen induced complete posterior vitreous detachment without morphological change of retina in juvenile rabbits.

[1]  N. Patton,et al.  OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE , 2020, Retina.

[2]  K. Kapoor,et al.  Updated Cost-Effectiveness of Intravitreal Ocriplasmin for Vitreomacular Adhesion and Macular Hole. , 2018, Ophthalmic surgery, lasers & imaging retina.

[3]  L. Duchateau,et al.  Visual Function Response to Ocriplasmin for the Treatment of Vitreomacular Traction and Macular Hole: The OASIS Study. , 2017, Investigative ophthalmology & visual science.

[4]  L. Feiner,et al.  Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial. , 2016, Ophthalmology.

[5]  Yung-Sung Lee,et al.  Plasmin Enzyme-Assisted Vitrectomy in Pediatric Patients with Vitreoretinal Diseases , 2016, Ophthalmic Research.

[6]  A. Capone,et al.  A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF INTRAVITREAL OCRIPLASMIN IN PEDIATRIC PATIENTS SCHEDULED FOR VITRECTOMY , 2016, Retina.

[7]  P. Kaiser,et al.  Improvement in Patient-Reported Visual Function After Ocriplasmin for Vitreomacular Adhesion: Results of the Microplasmin for Intravitreous Injection-Traction Release Without Surgical Treatment (MIVI-TRUST) Trials. , 2015, JAMA ophthalmology.

[8]  A. Kampik,et al.  ASSOCIATION BETWEEN ANATOMICAL RESOLUTION AND FUNCTIONAL OUTCOMES IN THE MIVI-TRUST STUDIES USING OCRIPLASMIN TO TREAT SYMPTOMATIC VITREOMACULAR ADHESION/VITREOMACULAR TRACTION, INCLUDING WHEN ASSOCIATED WITH MACULAR HOLE , 2015, Retina.

[9]  Xianqun Fan,et al.  Enzyme-induced vitreolysis can alleviate the progression of diabetic retinopathy through the HIF-1α pathway. , 2013, Investigative ophthalmology & visual science.

[10]  E. Rahimy,et al.  Ocriplasmin for Vitreoretinal Diseases , 2012, Journal of biomedicine & biotechnology.

[11]  Chi-Hsien Liu,et al.  Efficient vitreolysis by combining plasmin and sulfur hexafluoride injection in a preclinical study in rabbit eyes , 2012, Molecular vision.

[12]  A. Kampik,et al.  Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. , 2012, The New England journal of medicine.

[13]  M. Trese,et al.  POSTERIOR VITREOUS DETACHMENT WITH MICROPLASMIN ALTERS THE RETINAL PENETRATION OF INTRAVITREAL BEVACIZUMAB (AVASTIN) IN RABBIT EYES , 2011, Retina.

[14]  W. Mo,et al.  Microplasmin Degrades Fibronectin and Laminin at Vitreoretinal Interface and Outer Retina during Enzymatic Vitrectomy , 2009, Current eye research.

[15]  A. Gandorfer.  Objective of pharmacologic vitreolysis. , 2009, Developments in ophthalmology.

[16]  B. Willekens,et al.  Microplasmin: ex vivo characterization of its activity in porcine vitreous. , 2009, Investigative ophthalmology & visual science.

[17]  A. Gandorfer.  Microplasmin-assisted vitrectomy. , 2009, Developments in ophthalmology.

[18]  Richard F Spaide,et al.  Ultrastructural correlation of spectral-domain optical coherence tomographic findings in vitreomacular traction syndrome. , 2008, American journal of ophthalmology.

[19]  A. Gandorfer,et al.  Enzymatic vitreous disruption , 2008, Eye.

[20]  W. Mo,et al.  Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator , 2008, Eye.

[21]  M. Trese,et al.  PLASMIN ENZYME-ASSISTED VITRECTOMY FOR PRIMARY AND REOPERATED EYES WITH STAGE 5 RETINOPATHY OF PREMATURITY , 2008, Retina.

[22]  George A. Williams,et al.  Pediatric traumatic macular hole: results of autologous plasmin enzyme-assisted vitrectomy. , 2007, American journal of ophthalmology.

[23]  George A. Williams,et al.  PLASMIN ENZYME-ASSISTED VITREORETINAL SURGERY IN CONGENITAL X-LINKED RETINOSCHISIS: Surgical Techniques Based on a New Classification System , 2007, Retina.

[24]  W. Freeman,et al.  CHANGES OF INTRAOCULAR PRESSURE AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB (AVASTIN) , 2007, Retina.

[25]  M. Trese,et al.  POSTERIOR HYALOID CONTRACTURE IN PEDIATRIC VITREORETINOPATHIES , 2006, Retina.

[26]  A. Mizota,et al.  Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. , 2005, Investigative ophthalmology & visual science.

[27]  J. Sebag.  Anomalous posterior vitreous detachment: a unifying concept in vitreo-retinal disease , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[28]  A. Kampik,et al.  Posterior vitreous detachment induced by microplasmin. , 2004, Investigative ophthalmology & visual science.

[29]  N. Nagai,et al.  Recombinant human microplasmin: production and potential therapeutic properties , 2003, Journal of thrombosis and haemostasis : JTH.

[30]  George A. Williams,et al.  Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. , 1998, Ophthalmology.

[31]  J. Sebag.  Age-related differences in the human vitreoretinal interface. , 1991, Archives of ophthalmology.